GlassScriptPhysician profile
Thaddeus C West
NPI 1932169034
$1,417.96
in general payments reported to CMS, 2019-2025
14 companies · $34.85 in 2025
The $34.85 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.50 · 2021: $226 · 2022: $321 · 2023: $512 · 2024: $265 · 2025: $34.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $435.08 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $229.45 | 2022-2024 | Vraylar, Ubrelvy, Qulipta |
| Irhythm Technologies, INC. | $118.18 | 2022-2023 | Zio Xt Patch |
| Amgen INC. | $109.77 | 2021-2024 | Otezla, Repatha |
| Eisai INC. | $89.14 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.27 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $67.41 | 2022-2023 | Verquvo, Belsomra, Gardasil 9 |
| Abbott Laboratories | $63.83 | 2023-2024 | Freestyle Libre 2, Proclaim |
| Pfizer INC. | $62.24 | 2021-2024 | |
| Dexcom, INC. | $49.44 | 2022-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $43.78 | 2021 | |
| Lilly USA, LLC | $43.53 | 2022-2023 | Jardiance, Emgality |
| Exact Sciences Corporation | $18.13 | 2024 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thaddeus West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.